Technology | September 11, 2014

iCAD to Showcase its Electronic Brachytherapy Solutions and Services at ASTRO

iCAD's Xoft Axxent electronic brachytherapy (eBx) system

September 11, 2014 — iCAD Inc. will debut the company's latest technological advances and present updates on clinical data and patient outcomes using the Xoft Axxent electronic brachytherapy (eBx) system in the treatment of cancer during the upcoming American Society for Therapeutic Radiology and Oncology (ASTRO) meeting, Sept. 14-17.

Throughout the meeting iCAD will also showcase its expanded and comprehensive software and service offerings following the recent acquisitions of DermEbx and Radion, and will highlight innovations in technology with live product demonstrations of its Xoft system at booth #1938.

"This is a very exciting year for iCAD as we have significantly expanded our position as the industry's leading comprehensive solution provider in eBx. We look forward to outlining the elements of our new solutions and services and to giving customers a hands-on experience with our recent advances to the technology platforms, including the debut of our Axxent SPX controller, the latest extension of the Xoft system product line," said Ken Ferry, president and CEO of iCAD. "With our progress this year, iCAD is uniquely positioned to provide significant technology and service advantages to our valued customers and their patients."

"We continue to be encouraged by the positive data presented on the Xoft system for the treatment of non-melanoma skin cancer, as it further demonstrates the system's distinct clinical and cosmetic advantages," added Ferry.

During ASTRO iCAD will debut the new Axxent SPX controller, the latest extension of the Axxent product line. The Axxent SPX controller features a streamlined design to support enhanced mobility and flexibility for delivery of electronic brachytherapy treatment in a wider range of healthcare settings, including smaller treatment rooms. The controller also features new software and an enhanced barcode scanning function that offers significant workflow benefits and improved technology support for HIPAA compliance. These features are also now available on the multiplatform Axxent MPX controller, which remains commercially available as the company's platform product approved for use in all indications including breast intraoperative radiation therapy (IORT), breast accelerated partial breast irradiation (APBI), skin, endometrial and cervical cancer treatments.

"Electronic brachytherapy allows radiation oncologists to expand the reach of HDR [high-dose-rate] brachytherapy beyond conventional shielded vaults. It inherently offers safety for patients and personnel, target flexibility for challenging anatomic areas and fine radiation dose control. The new streamlined design may be easier to integrate into smaller spaces in many clinical facilities," said Rakesh Patel, M.D., medical director at the Targeted Radiation Institutes in the East and South Bay Areas in California.

For more information: www.xoftinc.com, www.icadmed.com

Related Content

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve